CHOO CHEE KONG purchased 35.2% of their position (112K shares) of CYTOMED THERAPEUTICS LTD on the open market
Open‑market purchase worth $128.8K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/15/2026ACC: 0001493152-26-028589
Director10% Owner
Since Mar 2023
+112K
Net shares
Net buyer
$128.8K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
112K acquired
Non-Derivative Transactions1
Ordinary Shares, no par value per share
Direct
Shares
+112K
Price / share
$1.15
Trade value
$128.78K
% of position
35.2%
5/13/2026
318.32K→430.32K
Total
Net shares
+112K
Net value
$128.78K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, no par value per share Direct | 5/13/2026 | P · Purchase | +112K | $1.15 | $128.78K | 35.2% | 318.32K | 430.32K |
| Total | +112K | $128.78K | ||||||
Derivative Transactions0
No derivative transactions reported